DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis

Effects of Ganjianglingzhu Decoction on Lean Non-Alcoholic Fatty Liver Disease in Mice Based on Untargeted Metabolomics
著者:: Nan Tang, 等
出版事項: (2024-04-01)

Deciphering the role of aberrant DNA methylation in NAFLD and NASH
著者:: Meenakshi Vachher, 等
出版事項: (2022-10-01)

Case report: The spectrum of SMPD1 pathogenic variants in Hungary
著者:: Maria Judit Molnar, 等
出版事項: (2023-06-01)

Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis.
著者:: Sumit Kar, 等
出版事項: (2019-01-01)

SMPD1 expression profile and mutation landscape help decipher genotype–phenotype association and precision diagnosis for acid sphingomyelinase deficiency
著者:: Ruisong Wang, 等
出版事項: (2023-03-01)

High expression of SMPD4 promotes liver cancer and is associated with poor prognosis
著者:: Rongyue Wang, 等
出版事項: (2025-04-01)

Machine learning-based integration reveals reliable biomarkers and potential mechanisms of NASH progression to fibrosis
著者:: Jiahui Feng, 等
出版事項: (2025-04-01)

Effect of pegbelfermin on NASH and fibrosis-related biomarkers and correlation with histological response in the FALCON 1 trial
著者:: Elizabeth A. Brown, 等
出版事項: (2023-04-01)

Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis
著者:: Shi-Yi Lyu, 等
出版事項: (2023-03-01)

Correction: Evaluation of CEP55, SERPINE1 and SMPD3 genes and proteins as diagnostic and prognostic biomarkers in gastric carcinoma in Egyptian patients
著者:: Marwa Sayed Abdel-Tawab, 等
出版事項: (2023-02-01)

Cloning of SMPD in Racomitrium canescens and analysis of its responses to drought and high-temperature stress
著者:: BAO Wei, WANG Jingjing, SHA Wei, ZHANG Meijuan, PENG Yifang, MA Tianyi*
出版事項: (2025-08-01)

SMPD2 affects the prognosis of cancer patients by mediating lipid metabolism and the immune microenvironment
著者:: Qing-Yan Li, 等
出版事項: (2025-09-01)

Challenging the conventional wisdom: Re‐evaluating Smpd3's role in extracellular vesicle biogenesis
著者:: Marlies Burgelman, 等
出版事項: (2024-11-01)

Molecular basis for the catalytic mechanism of human neutral sphingomyelinases 1 (hSMPD2)
著者:: Jingbo Yi, 等
出版事項: (2023-11-01)

Corrigendum: Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis
著者:: Shi-Yi Lyu, 等
出版事項: (2023-08-01)

Exosomes mediate Zika virus transmission through SMPD3 neutral Sphingomyelinase in cortical neurons
著者:: Wenshuo Zhou, 等
出版事項: (2019-01-01)

Epigenome-wide methylation analysis shows phosphonoethylamine alleviates aberrant DNA methylation in NASH caused by Pcyt2 deficiency.
著者:: Sophie Grapentine, 等
出版事項: (2025-01-01)

CD4+ T cell activation and inflammation in NASH-related fibrosis
著者:: Yunfeng Zhou, 等
出版事項: (2022-08-01)

DNA methylation modification in Idiopathic pulmonary fibrosis
著者:: Lu Ren, 等
出版事項: (2024-06-01)

Proximity Ligation Mapping of Microcephaly Associated SMPD4 Shows Association with Components of the Nuclear Pore Membrane
著者:: Alexandra C. A. Piët, 等
出版事項: (2022-02-01)

Effect of Procysteine on aging-associated changes in hepatic GSH and SMase: evidence for transcriptional regulation of smpd3[S]
著者:: Gergana Deevska, 等
出版事項: (2014-10-01)

Serum Paraoxonase-Early Diagnostic Biomarker in NASH/NAFLD
著者:: Jyotchna Devi Bade, 等
出版事項: (2019-10-01)

Spatial Computational Hepatic Molecular Biomarker Reveals LSEC Role in Midlobular Liver Zonation Fibrosis in DILI and NASH Liver Injury
著者:: Munish Puri
出版事項: (2024-03-01)

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
著者:: Hyeyeon Hong, 等
出版事項: (2024-06-01)

Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH
著者:: Davide Povero, 等
出版事項: (2020-09-01)

Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets?
著者:: Alexandra Zisser, 等
出版事項: (2021-03-01)

The Role of the Histone Methyltransferase EZH2 in Liver Inflammation and Fibrosis in STAM NASH Mice
著者:: Seul Lee, 等
出版事項: (2020-05-01)

Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model
著者:: J.T. Stefano, 等
出版事項: (2015-05-01)

Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model
著者:: J.T. Stefano, 等
出版事項: (2015-02-01)

Favorable clinical response to olipudase alfa in a patient with two variants of uncertain significance in SMPD1: a case report
著者:: Luz María Sánchez-Sánchez, 等
出版事項: (2025-09-01)

Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR−/− mice
著者:: Dawn Thompson, 等
出版事項: (2023-03-01)

Three-years misdiagnosis of Niemann Pick disease type B with novel mutations in SMPD1 gene as Budd-Chiari syndrome
著者:: Zhe-wen Zhou, 等
出版事項: (2022-09-01)

Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis
著者:: Momoko Hayashi, 等
出版事項: (2023-01-01)

SLC7A11-ROS/αKG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression
著者:: Tingting Lv, 等
出版事項: (2024-06-01)

Hepatocyte-targeted siTAZ therapy lowers liver fibrosis in NASH diet-fed chimeric mice with hepatocyte-humanized livers
著者:: Xiaobo Wang, 等
出版事項: (2023-12-01)

Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis: Molecular and Multicellular Control of Evolving Diseased States
著者:: Jérôme Eeckhoute
出版事項: (2022-08-01)